| Serial Number | 79238385 |
| Word Mark | OMERO |
| Filing Date | Tuesday, May 29, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 16, 2019 |
| Registration Number | 5802880 |
| Registration Date | Tuesday, July 16, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 30, 2019 |
| Description of Mark | The mark consists of a hexagonal design made up of six triangles with curved sides, with the upper left triangle being dark blue, the upper right triangle being green, the right triangle being dark blue, the bottom right triangle being light blue, the bottom left triangle being dark blue and the left triangle being red. In the middle of the foregoing is a dark blue circle. To the right of the foregoing is the word "OMERO", with the first "O" in red, the "M" in green, the "E" in light blue, and the "RO" in dark blue. All the foregoing appears against a white background. |
| Goods and Services | Computer software, including computer software downloadable from the Internet, for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; data access and data management software tools for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; downloadable electronic publications in the nature of scientific journals, periodicals and newsletters relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; * none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof * |
| Amendment to a Registration/Renewal Certificate | In the statement, line 14, after science, none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof is inserted and in line 22, 32 and 37 after services, none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof is inserted. |
| Indication of Colors claimed | The colors red, green, light blue, dark blue, and white are claimed as a feature of the mark. |
| Goods and Services | Business services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science, namely, management of biological and biomedical data and images for business enterprises; data processing services; all the aforesaid services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images, all being for use in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; * none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof * |
| Translation of Words in Mark | The English translation of "OMERO" in the mark is "humerus" or "Homer". |
| Goods and Services | Licensing of computer software for use in connection with the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images, all being for use in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; * none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof * |
| Goods and Services | Design and development of computer software, software tools, data access tools and data management tools; computer programming; installation, maintenance and repair of computer software; design of computer websites and maintenance thereof; software as a service (SAAS) featuring software for the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images in the field of healthcare, life science and biomedical science; all the aforesaid services relating to the accessing, visualisation, analysis, management, publication, sharing, storage and manipulation of biological and biomedical data and images, all being for use in the field of healthcare, life science and biomedical science; information, advisory and consultancy services in connection with the aforesaid services; * none of the foregoing for use by clinical care providers, future or current patients, or their families in connection with pharmaceuticals, biopharmaceuticals or therapeutic methods, or produced, designed, or marketed for providing medical and scientific research summaries, reports, or opinions regarding the efficacy, safety, pharmacological characteristics, or other properties of pharmaceutical and biopharmaceutical products, product candidates, development programs, therapeutic methods, drug delivery systems, medical treatments, or diagnostic methods, and relating to a specific disease, disorder, or category thereof * |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 14, 2018 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 14, 2018 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 14, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 14, 2018 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Glencoe Software Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 981043102 |
| Party Name | Glencoe Software Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 981043102 |
| Party Name | Glencoe Software Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 981043102 |
| Event Date | Event Description |
| Monday, September 17, 2018 | ASSIGNED TO EXAMINER |
| Thursday, August 9, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, August 14, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, August 18, 2018 | APPLICATION FILING RECEIPT MAILED |
| Thursday, September 20, 2018 | NON-FINAL ACTION WRITTEN |
| Friday, September 21, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 25, 2018 | REFUSAL PROCESSED BY MPU |
| Tuesday, September 25, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, October 13, 2018 | REFUSAL PROCESSED BY IB |
| Wednesday, February 13, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 13, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 21, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, February 21, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 26, 2019 | ASSIGNED TO LIE |
| Wednesday, February 27, 2019 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 27, 2019 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 27, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 5, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, March 5, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 5, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, March 5, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 25, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 26, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, April 10, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 17, 2019 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, April 17, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, April 30, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 30, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, May 3, 2019 | NOTIFICATION PROCESSED BY IB |
| Tuesday, July 16, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, October 16, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Friday, November 1, 2019 | FINAL DISPOSITION PROCESSED |
| Friday, November 1, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, November 22, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Friday, September 1, 2023 | TEAS SECTION 7 REQUEST RECEIVED |
| Tuesday, April 16, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, April 22, 2024 | AMENDMENT UNDER SECTION 7 - PROCESSED |
| Tuesday, July 16, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, May 31, 2024 | OTQR WITHDRAWAL FROM PUBLICATION |